Table 3.

Multivariate logistic regression analysis of patients in the training cohort.

Variable	β	SE	Wald	OR (95% CI)	P
Intercept	-27.798	3.713	56.046	–	< 0.001
Age	0.045	0.019	5.425	1.046 (1.008-1.088)	0.0198
T2DM Duration	0.226	0.039	34.006	1.254 (1.167-1.359)	< 0.001
SBP	0.032	0.011	8.889	1.033 (1.011-1.055)	0.0028
NLR	0.010	0.167	0.003	1.010 (0.728-1.400)	0.954
Scr	-0.001	0.016	0.006	0.999 (0.968-1.030)	0.937
UACR	0.014	0.003	21.192	1.014 (1.008-1.02)	< 0.001
eGFR	-0.009	0.011	0.721	0.991 (0.969-1.012)	0.396
LDL-C	-0.032	0.194	0.027	0.968 (0.662-1.417)	0.868
LAD	0.285	0.065	19.452	1.33 (1.178-1.519)	< 0.001
IVSd	0.189	0.366	0.268	1.208 (0.590-2.474)	0.605
LVPWd	0.846	0.218	15.074	2.33 (1.542-3.636)	< 0.001
LVMI	0.016	0.013	1.705	1.017 (0.992-1.042)	0.192

eGFR, Estimated glomerular filtration rate; IVSd, Interventricular septal thickness at end-diastole; LAD, Left atrial diameter; LDL-C, low-density lipoprotein cholesterol; LVPWd, Left ventricular posterior wall thickness at end-diastole; LVMI, Left ventricular mass index; NLR, neutrophil-to-lymphocyte ratio; SBP, systolic blood pressure; Scr, serum creatinine; T2DM Duration, duration of type 2 diabetes mellitus; UACR, urinary albumin-to-creatinine ratio.